BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18385666)

  • 1. Failure to phosphorylate AKT in podocytes from mice with early diabetic nephropathy promotes cell death.
    Tejada T; Catanuto P; Ijaz A; Santos JV; Xia X; Sanchez P; Sanabria N; Lenz O; Elliot SJ; Fornoni A
    Kidney Int; 2008 Jun; 73(12):1385-93. PubMed ID: 18385666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis occurs differentially according to glomerular size in diabetic kidney disease.
    Jung DS; Lee SH; Kwak SJ; Li JJ; Kim DH; Nam BY; Kang HY; Chang TI; Park JT; Han SH; Yoo TH; Kang SW
    Nephrol Dial Transplant; 2012 Jan; 27(1):259-66. PubMed ID: 21652547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy.
    Jung E; Kim J; Ho Kim S; Kim S; Cho MH
    Eur J Pharmacol; 2015 Aug; 761():116-24. PubMed ID: 25977232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cinacalcet-mediated activation of the CaMKKβ-LKB1-AMPK pathway attenuates diabetic nephropathy in db/db mice by modulation of apoptosis and autophagy.
    Lim JH; Kim HW; Kim MY; Kim TW; Kim EN; Kim Y; Chung S; Kim YS; Choi BS; Kim YS; Chang YS; Kim HW; Park CW
    Cell Death Dis; 2018 Feb; 9(3):270. PubMed ID: 29449563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of IRAK1 attenuates podocyte apoptosis in diabetic nephropathy through PI3K/Akt signaling pathway.
    Zhang Y; Chen X; Yuan L; Zhang Y; Wu J; Guo N; Chen X; Liu J
    Biochem Biophys Res Commun; 2018 Nov; 506(3):529-535. PubMed ID: 30361091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olmesartan Prevents Microalbuminuria in db/db Diabetic Mice Through Inhibition of Angiotensin II/p38/SIRT1-Induced Podocyte Apoptosis.
    Gu J; Yang M; Qi N; Mei S; Chen J; Song S; Jing Y; Chen M; He L; Sun L; Hu H; Li L; Wüthrich RP; Wu M; Mei C
    Kidney Blood Press Res; 2016; 41(6):848-864. PubMed ID: 27871084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury.
    Zhang L; Zhang Q; Liu S; Chen Y; Li R; Lin T; Yu C; Zhang H; Huang Z; Zhao X; Tan X; Li Z; Ye Z; Ma J; Zhang B; Wang W; Shi W; Liang X
    Kidney Int; 2017 Jul; 92(1):140-153. PubMed ID: 28318634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis.
    Isermann B; Vinnikov IA; Madhusudhan T; Herzog S; Kashif M; Blautzik J; Corat MA; Zeier M; Blessing E; Oh J; Gerlitz B; Berg DT; Grinnell BW; Chavakis T; Esmon CT; Weiler H; Bierhaus A; Nawroth PP
    Nat Med; 2007 Nov; 13(11):1349-58. PubMed ID: 17982464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice.
    Kosugi T; Nakayama T; Li Q; Chiodo VA; Zhang L; Campbell-Thompson M; Grant M; Croker BP; Nakagawa T
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F609-16. PubMed ID: 20015944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy.
    Choi SR; Lim JH; Kim MY; Kim EN; Kim Y; Choi BS; Kim YS; Kim HW; Lim KM; Kim MJ; Park CW
    Metabolism; 2018 Aug; 85():348-360. PubMed ID: 29462574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes.
    Stieger N; Worthmann K; Teng B; Engeli S; Das AM; Haller H; Schiffer M
    Metabolism; 2012 Aug; 61(8):1073-86. PubMed ID: 22365040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy.
    Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Liu BC
    Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1140-8. PubMed ID: 25921580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of Histone Deacetylase 9 Expression in Podocytes Attenuates Kidney Injury in Diabetic Nephropathy.
    Liu F; Zong M; Wen X; Li X; Wang J; Wang Y; Jiang W; Li X; Guo Z; Qi H
    Sci Rep; 2016 Sep; 6():33676. PubMed ID: 27633396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of C-jun N-terminal kinase improves insulin sensitivity but worsens albuminuria in experimental diabetes.
    Ijaz A; Tejada T; Catanuto P; Xia X; Elliot SJ; Lenz O; Jauregui A; Saenz MO; Molano RD; Pileggi A; Ricordi C; Fornoni A
    Kidney Int; 2009 Feb; 75(4):381-8. PubMed ID: 18971923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of BSF on Podocyte Apoptosis via Regulating the ROS-Mediated PI3K/AKT Pathway in DN.
    Cui FQ; Wang YF; Gao YB; Meng Y; Cai Z; Shen C; Liu ZQ; Jiang XC; Zhao WJ
    J Diabetes Res; 2019; 2019():9512406. PubMed ID: 31886291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentiation.
    Li SY; Huang PH; Yang AH; Tarng DC; Yang WC; Lin CC; Chen JW; Schmid-Schönbein G; Lin SJ
    Kidney Int; 2014 Aug; 86(2):358-69. PubMed ID: 24670409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocyte-specific knockout of cyclooxygenase 2 exacerbates diabetic kidney disease.
    Wang L; Sha Y; Bai J; Eisner W; Sparks MA; Buckley AF; Spurney RF
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F430-F439. PubMed ID: 28490532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of SHP-1 induced by hyperglycemia prevents insulin actions in podocytes.
    Drapeau N; Lizotte F; Denhez B; Guay A; Kennedy CR; Geraldes P
    Am J Physiol Endocrinol Metab; 2013 Jun; 304(11):E1188-98. PubMed ID: 23531619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Losartan affects glomerular AKT and mTOR phosphorylation in an experimental model of type 1 diabetic nephropathy.
    Mavroeidi V; Petrakis I; Stylianou K; Katsarou T; Giannakakis K; Perakis K; Vardaki E; Stratigis S; Ganotakis E; Papavasiliou S; Daphnis E
    J Histochem Cytochem; 2013 Jun; 61(6):433-43. PubMed ID: 23456824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.